» Articles » PMID: 34530895

15q26 Deletion in a Patient with Congenital Heart Defect, Growth Restriction and Intellectual Disability: Case Report and Literature Review

Overview
Journal Ital J Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2021 Sep 17
PMID 34530895
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: 15q26 deletion is a relatively rare chromosomal disorder, and it is described only in few cases. Patients with this aberration show many signs and symptoms, particularly pre- and postnatal growth restriction, developmental delay, microcephaly, intellectual disability and various congenital malformations.

Case Presentation: We report on a girl, 4 years old, of consanguineous parents, with a 15q26 deletion. Clinical manifestations included failure to thrive, developmental delay, microcephaly, dysmorphic facies with broad forehead, hypertelorism, narrowed eyelid slits and protruding columella. The patient also showed skeletal abnormalities, especially clinodactyly of the 5th finger, varus equine right foot and left club foot. Additionally, she had teething delay and divergent strabismus. Heart ultrasound displayed two atrial septal defects with left-to-right shunt, enlarging the right cavities. Routine cytogenetic analysis revealed a shortened 15q chromosome. Subsequent array analysis disclosed a terminal 9.15 Mb deletion at subband 15q26.1-q26.3. Four candidate genes associated with 15q26 deletion phenotype were within the deleted region, i.e. IGF1R, NR2F2, CHD2 and MEF2A.

Conclusion: We report on an additional case of 15q26 monosomy, characterized by array-CGH. Molecular cytogenetic analysis allowed us to identify the exact size of the deletion, and four candidate genes for genotype-phenotype correlation. 15q26 monosomy should be considered when growth retardation is associated with hearing anomalies and congenital heart defect, especially atrioventricular septal defects (AVSDs) and/or aortic arch anomaly (AAA).

Citing Articles

Drayer Syndrome due to Chromosome 15q26.3 Deletion: Response to Growth Hormone Treatment.

Dincer B, Ozdemir E, Cetincelik U, Ucar A Sisli Etfal Hastan Tıp Bul. 2025; 58(4):521-523.

PMID: 39816431 PMC: 11729826. DOI: 10.14744/SEMB.2024.01879.


Mosaic derivative chromosomes at chorionic villi (CV) sampling are expression of genomic instability and precursors of cryptic disease-causing rearrangements: report of further four cases.

Vitetta G, Desiderio L, Baccolini I, Uliana V, Lanzoni G, Ghi T Mol Cytogenet. 2024; 17(1):8.

PMID: 38589928 PMC: 11003029. DOI: 10.1186/s13039-024-00675-3.


Breaking the silence: A qualitative exploration of parental perspectives of children with Goldenhar Syndrome.

Hitchen R, Woolhouse M, Holch P Heliyon. 2024; 10(3):e24328.

PMID: 38318028 PMC: 10839885. DOI: 10.1016/j.heliyon.2024.e24328.


Epigenomic signature of major congenital heart defects in newborns with Down syndrome.

Mouat J, Li S, Myint S, Laufer B, Lupo P, Schraw J Hum Genomics. 2023; 17(1):92.

PMID: 37803336 PMC: 10559462. DOI: 10.1186/s40246-023-00540-1.


Epigenomic signature of major congenital heart defects in newborns with Down syndrome.

Mouat J, Li S, Myint S, Laufer B, Lupo P, Schraw J medRxiv. 2023; .

PMID: 37205408 PMC: 10187438. DOI: 10.1101/2023.05.02.23289417.


References
1.
Choi J, Kang M, Kim G, Hong M, Jin H, Lee B . Clinical and functional characteristics of a novel heterozygous mutation of the IGF1R gene and IGF1R haploinsufficiency due to terminal 15q26.2->qter deletion in patients with intrauterine growth retardation and postnatal catch-up growth failure. J Clin Endocrinol Metab. 2010; 96(1):E130-4. DOI: 10.1210/jc.2010-1789. View

2.
Lopez I, Bafalliu J, Bernabe M, Garcia F, Costa M, Guillen-Navarro E . Prenatal diagnosis of de novo deletions of 8p23.1 or 15q26.1 in two fetuses with diaphragmatic hernia and congenital heart defects. Prenat Diagn. 2006; 26(6):577-80. DOI: 10.1002/pd.1468. View

3.
Capelli L, Krepischi A, Gurgel-Giannetti J, Mendes M, Rodrigues T, Varela M . Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency. Eur J Med Genet. 2011; 55(2):132-4. DOI: 10.1016/j.ejmg.2011.10.004. View

4.
Forbes B, Blyth A, Wit J . Disorders of IGFs and IGF-1R signaling pathways. Mol Cell Endocrinol. 2020; 518:111035. DOI: 10.1016/j.mce.2020.111035. View

5.
Abuzzahab M, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E . IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med. 2003; 349(23):2211-22. DOI: 10.1056/NEJMoa010107. View